WO2010007318A3 - NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET - Google Patents
NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET Download PDFInfo
- Publication number
- WO2010007318A3 WO2010007318A3 PCT/FR2009/051408 FR2009051408W WO2010007318A3 WO 2010007318 A3 WO2010007318 A3 WO 2010007318A3 FR 2009051408 W FR2009051408 W FR 2009051408W WO 2010007318 A3 WO2010007318 A3 WO 2010007318A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- imidazo
- production
- application
- pharmaceutical compositions
- met inhibitors
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000005238 imidazo[1,2-a]pyrimidines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2009272518A AU2009272518A1 (en) | 2008-07-18 | 2009-07-16 | Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as MET inhibitors |
BRPI0915920-7A BRPI0915920A2 (pt) | 2008-07-18 | 2009-07-16 | derivados imidazo [1,2-a]pirimidina, o respectivo processo de preparo, a respectiva aplicação a título de medicamentos, composições farmacêuticas e nova utilização notadamente com inibidores de met |
MX2011000670A MX2011000670A (es) | 2008-07-18 | 2009-07-16 | Nuevos derivados de imidazo [1, 2-a] pirimidina, su procedimiento de preparación, su uso como medicamentos, composiciones farmacéuticas y nuevo uso particularmente como inhibidores de met. |
CA2730964A CA2730964A1 (fr) | 2008-07-18 | 2009-07-16 | Nouveaux derives imidazo[1,2-a]pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
EA201170224A EA201170224A1 (ru) | 2008-07-18 | 2009-07-16 | Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет |
CN200980136540XA CN102159577A (zh) | 2008-07-18 | 2009-07-16 | 咪唑并[1,2-a]嘧啶衍生物,其制备方法,其作为药物、药物组合物的应用以及作为MET抑制剂的用途 |
JP2011517980A JP2011528339A (ja) | 2008-07-18 | 2009-07-16 | イミダゾ[1,2−a]ピリミジン誘導体、この調製方法、薬剤としてのこの適用、医薬組成物、およびMET阻害剤としてのこの使用 |
EP09737062A EP2318414A2 (fr) | 2008-07-18 | 2009-07-16 | Derives imidazo [1,2-a] pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation comme inhibiteurs de met |
TNP2010000619A TN2010000619A1 (fr) | 2009-07-16 | 2010-12-29 | NOUVEAUX DERIVES IMIDAZO [1,2-a] PYRIMIDINE LEUR PROCEDE DE PREPARATION LEUR APPLICATION A TITRE DE MEDICAMENTS COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET |
IL210708A IL210708A0 (en) | 2008-07-18 | 2011-01-17 | Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
ZA2011/00428A ZA201100428B (en) | 2008-07-18 | 2011-01-17 | Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
US13/007,830 US20110263593A1 (en) | 2008-07-18 | 2011-01-17 | NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS |
MA33618A MA32564B1 (fr) | 2008-07-18 | 2011-02-15 | NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0804086 | 2008-07-18 | ||
FR0804086A FR2933982A1 (fr) | 2008-07-18 | 2008-07-18 | Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/007,830 Continuation US20110263593A1 (en) | 2008-07-18 | 2011-01-17 | NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010007318A2 WO2010007318A2 (fr) | 2010-01-21 |
WO2010007318A3 true WO2010007318A3 (fr) | 2010-04-08 |
Family
ID=40352183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2009/051408 WO2010007318A2 (fr) | 2008-07-18 | 2009-07-16 | NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET |
Country Status (26)
Country | Link |
---|---|
US (1) | US20110263593A1 (fr) |
EP (1) | EP2318414A2 (fr) |
JP (1) | JP2011528339A (fr) |
KR (1) | KR20110043680A (fr) |
CN (1) | CN102159577A (fr) |
AR (1) | AR072820A1 (fr) |
AU (1) | AU2009272518A1 (fr) |
BR (1) | BRPI0915920A2 (fr) |
CA (1) | CA2730964A1 (fr) |
CL (1) | CL2011000118A1 (fr) |
CO (1) | CO6341634A2 (fr) |
CR (1) | CR20110031A (fr) |
DO (1) | DOP2011000019A (fr) |
EA (1) | EA201170224A1 (fr) |
EC (1) | ECSP11010765A (fr) |
FR (1) | FR2933982A1 (fr) |
IL (1) | IL210708A0 (fr) |
MA (1) | MA32564B1 (fr) |
MX (1) | MX2011000670A (fr) |
NI (1) | NI201100020A (fr) |
PE (1) | PE20110584A1 (fr) |
SV (1) | SV2011003811A (fr) |
TW (1) | TW201011025A (fr) |
UY (1) | UY31998A (fr) |
WO (1) | WO2010007318A2 (fr) |
ZA (1) | ZA201100428B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
WO2011121223A1 (fr) | 2010-03-30 | 2011-10-06 | Sanofi-Aventis | Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met |
CN102796103A (zh) * | 2011-05-23 | 2012-11-28 | 南京英派药业有限公司 | 6-(芳基甲酰)咪唑并[1,2-a]嘧啶和6-(芳基甲酰)[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用 |
WO2016089648A1 (fr) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Inhibiteurs de bach1 en combinaison avec des activateurs de nrf2 et compositions pharmaceutiques les contenant |
JP7304855B2 (ja) | 2017-11-14 | 2023-07-07 | ザ チルドレンズ メディカル センター コーポレーション | 新規イミダゾピリミジン化合物およびそれらの使用 |
JP7382316B2 (ja) | 2017-11-14 | 2023-11-16 | ザ チルドレンズ メディカル センター コーポレーション | ヒト免疫応答をモジュレートするためのイミダゾピリミジンの使用 |
CA3129665A1 (fr) | 2019-03-21 | 2020-09-24 | Onxeo | Molecule dbait associee a un inhibiteur de kinase pour le traitement du cancer |
KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2785157A (en) * | 1952-11-05 | 1957-03-12 | Eastman Kodak Co | Benzothiazoleazoaniline compounds |
US6528510B1 (en) * | 1998-09-11 | 2003-03-04 | Warner-Lambert Company | HIV protease inhibitors |
US20030153568A1 (en) * | 2000-02-07 | 2003-08-14 | Basf Aktiengesellschaft Ludwigshafen, Germany | Benzothiazole derivatives |
WO2006038001A1 (fr) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Derives d’aminopyrimidine en tant qu’inhibiteurs de la jnk |
EP1674466A1 (fr) * | 2004-12-27 | 2006-06-28 | 4Sc Ag | Derives benzazoles 2,5- et 2-6-disubstitues utiles comme des inhibiteurs de la proteine kinase |
WO2008064157A1 (fr) * | 2006-11-22 | 2008-05-29 | Incyte Corporation | Imidazotriazines et imidazopyrimidines utilisées en tant qu'inhibiteurs de kinases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2294117A1 (fr) * | 1997-07-03 | 1999-01-14 | Dupont Pharmaceuticals Company | Imidazopyrimidines et imidazopyridines utiles pour traiter des troubles neurologiques |
EP1711495A2 (fr) * | 2004-01-23 | 2006-10-18 | Amgen Inc. | Quinolines, chinazolines, pyridines et pyrimidines et leur utilsation dans le traitement d'inflammation, angiogenèse et le cancer |
-
2008
- 2008-07-18 FR FR0804086A patent/FR2933982A1/fr not_active Withdrawn
-
2009
- 2009-07-16 PE PE2011000049A patent/PE20110584A1/es not_active Application Discontinuation
- 2009-07-16 TW TW098124145A patent/TW201011025A/zh unknown
- 2009-07-16 CA CA2730964A patent/CA2730964A1/fr not_active Abandoned
- 2009-07-16 MX MX2011000670A patent/MX2011000670A/es not_active Application Discontinuation
- 2009-07-16 CN CN200980136540XA patent/CN102159577A/zh active Pending
- 2009-07-16 JP JP2011517980A patent/JP2011528339A/ja not_active Withdrawn
- 2009-07-16 BR BRPI0915920-7A patent/BRPI0915920A2/pt not_active IP Right Cessation
- 2009-07-16 AU AU2009272518A patent/AU2009272518A1/en not_active Abandoned
- 2009-07-16 WO PCT/FR2009/051408 patent/WO2010007318A2/fr active Application Filing
- 2009-07-16 KR KR1020117003698A patent/KR20110043680A/ko not_active Application Discontinuation
- 2009-07-16 EA EA201170224A patent/EA201170224A1/ru unknown
- 2009-07-16 EP EP09737062A patent/EP2318414A2/fr not_active Withdrawn
- 2009-07-17 AR ARP090102728A patent/AR072820A1/es unknown
- 2009-07-17 UY UY0001031998A patent/UY31998A/es not_active Application Discontinuation
-
2011
- 2011-01-17 NI NI201100020A patent/NI201100020A/es unknown
- 2011-01-17 ZA ZA2011/00428A patent/ZA201100428B/en unknown
- 2011-01-17 SV SV2011003811A patent/SV2011003811A/es unknown
- 2011-01-17 DO DO2011000019A patent/DOP2011000019A/es unknown
- 2011-01-17 US US13/007,830 patent/US20110263593A1/en not_active Abandoned
- 2011-01-17 IL IL210708A patent/IL210708A0/en unknown
- 2011-01-17 CR CR20110031A patent/CR20110031A/es not_active Application Discontinuation
- 2011-01-18 CL CL2011000118A patent/CL2011000118A1/es unknown
- 2011-01-18 EC EC2011010765A patent/ECSP11010765A/es unknown
- 2011-01-18 CO CO11004605A patent/CO6341634A2/es not_active Application Discontinuation
- 2011-02-15 MA MA33618A patent/MA32564B1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2785157A (en) * | 1952-11-05 | 1957-03-12 | Eastman Kodak Co | Benzothiazoleazoaniline compounds |
US6528510B1 (en) * | 1998-09-11 | 2003-03-04 | Warner-Lambert Company | HIV protease inhibitors |
US20030153568A1 (en) * | 2000-02-07 | 2003-08-14 | Basf Aktiengesellschaft Ludwigshafen, Germany | Benzothiazole derivatives |
WO2006038001A1 (fr) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Derives d’aminopyrimidine en tant qu’inhibiteurs de la jnk |
EP1674466A1 (fr) * | 2004-12-27 | 2006-06-28 | 4Sc Ag | Derives benzazoles 2,5- et 2-6-disubstitues utiles comme des inhibiteurs de la proteine kinase |
WO2008064157A1 (fr) * | 2006-11-22 | 2008-05-29 | Incyte Corporation | Imidazotriazines et imidazopyrimidines utilisées en tant qu'inhibiteurs de kinases |
Non-Patent Citations (2)
Title |
---|
PAPKE K ET AL: "On the rhodanation of halogen substituted anilines. 24. On the organic rhodan compounds", DIE PHARMAZIE, GOVI VERLAG PHARMAZEUTISCHER VERLAG GMBH, ESCHBORN, DE, vol. 22, no. 6, 1 May 1967 (1967-05-01), pages 229 - 233, XP009128816, ISSN: 0031-7144 * |
VARA PRASAD J V N ET AL: "Thiocyanation of alkylanilines. A simple and efficient synthesis of thiosulfonates containing 2-aminobenzothiazole", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 41, no. 21, 1 May 2000 (2000-05-01), pages 4065 - 4068, XP004204495, ISSN: 0040-4039 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0915920A2 (pt) | 2018-07-10 |
PE20110584A1 (es) | 2011-09-10 |
AR072820A1 (es) | 2010-09-22 |
CN102159577A (zh) | 2011-08-17 |
KR20110043680A (ko) | 2011-04-27 |
SV2011003811A (es) | 2011-04-29 |
CA2730964A1 (fr) | 2010-01-21 |
ECSP11010765A (es) | 2011-02-28 |
CL2011000118A1 (es) | 2011-07-15 |
CO6341634A2 (es) | 2011-11-21 |
JP2011528339A (ja) | 2011-11-17 |
MA32564B1 (fr) | 2011-08-01 |
IL210708A0 (en) | 2011-03-31 |
TW201011025A (en) | 2010-03-16 |
FR2933982A1 (fr) | 2010-01-22 |
US20110263593A1 (en) | 2011-10-27 |
UY31998A (es) | 2010-02-26 |
EP2318414A2 (fr) | 2011-05-11 |
NI201100020A (es) | 2011-07-21 |
DOP2011000019A (es) | 2011-02-15 |
MX2011000670A (es) | 2011-04-11 |
AU2009272518A1 (en) | 2010-01-21 |
WO2010007318A2 (fr) | 2010-01-21 |
CR20110031A (es) | 2011-03-14 |
ZA201100428B (en) | 2012-03-28 |
EA201170224A1 (ru) | 2011-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010007318A3 (fr) | NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET | |
WO2010007316A3 (fr) | NOUVEAUX DERIVES TRIAZOLO(4,3-a)PYRIDINE,LEUR PROCEDE DE PREPARATION,LEUR APPLICATION A TITRE DE MEDICAMENTS,COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET | |
EA201170223A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И НОВОЕ ПРИМЕНЕНИЕ, В ЧАСТНОСТИ, В КАЧЕСТВЕ ИНГИБИТОРОВ МЕТ | |
SG10201804791UA (en) | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof | |
SI1966208T1 (sl) | (1-aza-biciklo(3.3.1)non-4-il)-(5-(1H-indol-5-il)-heteroaril)-amini kot holinergični ligandi n-AChR za zdravljenje psihotičnih in nevrodegenerativnih motenj | |
WO2007058832A3 (fr) | INHIBITEURS DES KINASES Tec | |
WO2012044727A3 (fr) | Procédé de fabrication de dérivés de pyrimidine | |
WO2006117211A3 (fr) | Derives d'uree, procedes pour leur fabrication et utilisations de ces derives | |
NO20091858L (no) | Hydrobenzamid derivater som inhibitorer av HSP90 | |
WO2013004995A8 (fr) | Composés pyrimidinones et leur utilisation | |
WO2007083017A3 (fr) | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases | |
WO2010089510A3 (fr) | Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique | |
WO2004073595A3 (fr) | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation | |
WO2011047055A8 (fr) | Nouveaux inhibiteurs de mek, utiles dans le traitement des maladies | |
WO2013024358A3 (fr) | Composés amines hétérocycliques substitués comme inhibiteurs de la protéine de transfert d'ester cholesterylique (cetp) | |
WO2009106751A3 (fr) | Dérivés de n-heterocyclique-6-heterocyclique-imidazo[1,2- a]pyridiνe-2-carb0xamides, leur préparation et leur application en thérapeutique | |
WO2007026041A3 (fr) | Composes quinoniques antitumoraux et leurs derives, procede d'obtention de ceux-ci et applications correspondantes | |
WO2008090200A3 (fr) | Dérivés de 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine | |
WO2012136356A8 (fr) | Dérivés de la 6,7-dihydro-[1,3,4] thiadiazolo-[3,2-a][1,3] diazépine et compositions pharmaceutiques les contenant en tant qu'agent hypnotique ou anesthésique et procédé pour leur préparation | |
WO2009101432A3 (fr) | Procédé de préparation de dérivés de pyridone 226 | |
TN2010000619A1 (fr) | NOUVEAUX DERIVES IMIDAZO [1,2-a] PYRIMIDINE LEUR PROCEDE DE PREPARATION LEUR APPLICATION A TITRE DE MEDICAMENTS COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET | |
WO2018109496A3 (fr) | Acides aminés non naturels | |
TH133827B (th) | ทริปโตไลด์โพรดรักชนิดใหม่ | |
TH105084B (th) | เกลือจำเพาะ, รูปแบบแอนไฮดรัสและรูปแบบที่เป็นผลึกของอนุพันธ์ไดไฮโดรพ์เทอริไดโอน | |
TH155337A (th) | เกลือฟีโนไธอะซีนไดอะมิเนียมและการใช้เกลือดังกล่าว phenothiazine diaminium salts and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980136540.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09737062 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 177/KOLNP/2011 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2730964 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2011517980 Country of ref document: JP Kind code of ref document: A Ref document number: 0123011 Country of ref document: KE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011010106 Country of ref document: EG Ref document number: 000049-2011 Country of ref document: PE Ref document number: CR2011-000031 Country of ref document: CR Ref document number: 2009737062 Country of ref document: EP Ref document number: MX/A/2011/000670 Country of ref document: MX Ref document number: 12011500120 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011000118 Country of ref document: CL Ref document number: 590582 Country of ref document: NZ Ref document number: 11004605 Country of ref document: CO |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009272518 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: DZP2011000081 Country of ref document: DZ |
|
ENP | Entry into the national phase |
Ref document number: 2009272518 Country of ref document: AU Date of ref document: 20090716 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20117003698 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201170224 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201101876 Country of ref document: UA |
|
ENP | Entry into the national phase |
Ref document number: PI0915920 Country of ref document: BR Kind code of ref document: A2 Effective date: 20110117 |